Skip to main content
Caplight Logo









Shanmu Biotechnology

Shanmu Biotechnology

Private
ShenzhenHealthcare & Life Scienceshttps://shanmu.ltd/

Last Round

Series A

May 6, 2026

Total Funding Raised

$22.2M

Company Overview

Shanmu Biotechnology is a health technology company that develops AI-powered, miniaturized medical robots for automated, non-invasive at-home urine analysis and chronic disease management.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Consumer Electronics

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

at-home urine analysismedical robotsmart toilethealth monitoringmicrofluidicsspectral analysisbiomarker trackingchronic illness managementconsumer health-techdigital healthremote patient monitoringRPMhealth IoTpreventive medicinewearable alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanmu Biotechnology Comparables

Compare Shanmu Biotechnology with similar companies based on industry and business-model similarity.

Shanmu Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medipee GmbH
87%
Vivoo
85%
Yellosis
84%

Shanmu Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 6, 2026
VC RoundJan 1, 2026
Pre SeedOct 1, 2025
Pre SeedJun 18, 2025
VC RoundJun 1, 2025
Pre Seed
Jun 6, 2024

Shanmu Biotechnology Investors

Notable investors and investment history

Shanmu Biotechnology investors
InvestorRounds
iCANX FundPre Seed
松禾资本 (Green Pine Capital Partners)Pre Seed
Songlin GroupPre Seed
Bojiang CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Completed a Pre Seed funding round.

Shanmu Biotechnology Filings

Explore SEC and related filing metadata, where available.

Shanmu Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Shanmu Biotechnology's valuation, stock price, and market status.

Is Shanmu Biotechnology a public or private company?

Shanmu Biotechnology is a private company.

What is the current stock price of Shanmu Biotechnology?

Shanmu Biotechnology is a private company with no public stock price. No recent secondary market data is available.

How much is Shanmu Biotechnology worth (valuation)?

Valuation information for Shanmu Biotechnology is not publicly available.

Can I buy Shanmu Biotechnology stock?

Shanmu Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Shanmu Biotechnology's last funding round?

Shanmu Biotechnology's most recent funding round was Series A on May 6, 2026.

Who are the main investors in Shanmu Biotechnology?

Key investors in Shanmu Biotechnology include Songlin Group.

Will Shanmu Biotechnology IPO soon?

No public IPO plans have been announced for Shanmu Biotechnology.

How can I track Shanmu Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanmu Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShenzhen
Year Founded2020
Last FundingMay 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?